Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Pflugers Arch
2016 Aug 01;4688:1375-87. doi: 10.1007/s00424-016-1844-3.
Show Gene links
Show Anatomy links
Electrophysiological characterization of a large set of novel variants in the SCN5A-gene: identification of novel LQTS3 and BrS mutations.
Ortiz-Bonnin B
,
Rinné S
,
Moss R
,
Streit AK
,
Scharf M
,
Richter K
,
Stöber A
,
Pfeufer A
,
Seemann G
,
Kääb S
,
Beckmann BM
,
Decher N
.
???displayArticle.abstract??? SCN5A encodes for the α-subunit of the cardiac voltage-gated sodium channel Nav1.5. Gain-of-function mutations in SCN5A are related to congenital long QT syndrome (LQTS3) characterized by delayed cardiac repolarization, leading to a prolonged QT interval in the ECG. Loss-of-function mutations in SCN5A are related to Brugada syndrome (BrS), characterized by an ST-segment elevation in the right precordial leads (V1-V3). The aim of this study was the characterization of a large set of novel SCN5A variants found in patients with different cardiac phenotypes, mainly LQTS and BrS. SCN5A variants of 13 families were functionally characterized in Xenopus laevis oocytes using the two-electrode voltage-clamp technique. We found in most of the cases, but not all, that the electrophysiology of the variants correlated with the clinically diagnosed phenotype. A susceptibility to develop LQTS can be suggested in patients carrying the variants S216L, K480N, A572D, F816Y, and G983D. However, taking the phenotype into account, the presence of the variants in genomic data bases, the mutational segregation, combined with our in vitro and in silico experiments, the variants S216L, S262G, K480N, A572D, F816Y, G983D, and T1526P remain as variants of unknown significance. However, the SCN5A variants R568H and A993T can be classified as pathogenic LQTS3 causing mutations, while R222stop and R2012H are novel BrS causing mutations.
Armstrong,
Inactivation of the sodium channel. II. Gating current experiments.
1977, Pubmed
Armstrong,
Inactivation of the sodium channel. II. Gating current experiments.
1977,
Pubmed
Baroudi,
Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes.
2000,
Pubmed
Beckmann,
Dual inheritance of sudden death from cardiovascular causes.
2008,
Pubmed
Bennett,
Molecular mechanism for an inherited cardiac arrhythmia.
1995,
Pubmed
,
Xenbase
Calloe,
Characterization and mechanisms of action of novel NaV1.5 channel mutations associated with Brugada syndrome.
2013,
Pubmed
Campuzano,
Determining the pathogenicity of genetic variants associated with cardiac channelopathies.
2015,
Pubmed
Chen,
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.
1998,
Pubmed
,
Xenbase
Clancy,
Non-equilibrium gating in cardiac Na+ channels: an original mechanism of arrhythmia.
2003,
Pubmed
Herren,
Post-translational modifications of the cardiac Na channel: contribution of CaMKII-dependent phosphorylation to acquired arrhythmias.
2013,
Pubmed
Huang,
Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes.
2006,
Pubmed
Jeevaratnam,
Delayed conduction and its implications in murine Scn5a(+/-) hearts: independent and interacting effects of genotype, age, and sex.
2011,
Pubmed
Makita,
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome.
2008,
Pubmed
Malfatto,
Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome.
1994,
Pubmed
Marangoni,
A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization.
2011,
Pubmed
Meisler,
Sodium channel mutations in epilepsy and other neurological disorders.
2005,
Pubmed
Moss,
The long QT syndrome. Prospective longitudinal study of 328 families.
1991,
Pubmed
Nishio,
D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome.
2009,
Pubmed
Olesen,
High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation.
2012,
Pubmed
Olson,
Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.
2005,
Pubmed
Parisi,
Coexistence of epilepsy and Brugada syndrome in a family with SCN5A mutation.
2013,
Pubmed
Probst,
Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation.
2006,
Pubmed
Probst,
SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome.
2009,
Pubmed
Probst,
Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease.
2003,
Pubmed
Rush,
A practical algorithm for solving dynamic membrane equations.
1978,
Pubmed
Schott,
Cardiac conduction defects associate with mutations in SCN5A.
1999,
Pubmed
Schwartz,
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.
2001,
Pubmed
Schwartz,
Long-QT syndrome: from genetics to management.
2012,
Pubmed
ten Tusscher,
Alternans and spiral breakup in a human ventricular tissue model.
2006,
Pubmed
Tester,
Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation.
2010,
Pubmed
Wang,
Cardiac sodium channel dysfunction in sudden infant death syndrome.
2007,
Pubmed
Wang,
Analysis of four novel variants of Nav1.5/SCN5A cloned from the brain.
2009,
Pubmed
Zhang,
Arrhythmic substrate, slowed propagation and increased dispersion in conduction direction in the right ventricular outflow tract of murine Scn5a+/- hearts.
2014,
Pubmed
